Patents by Inventor Lloyd E. Chambless

Lloyd E. Chambless has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11686736
    Abstract: The present disclosure relates to the field of laboratory diagnostics. Specifically, methods are disclosed for determining a patient's risk of suffering from heart failure (HF) based on the detection of NT-proBNP, troponin T, and/or a natriuretic peptide. Also disclosed are methods for improving both the accuracy and speed of HF risk models by incorporating biomarker data from patient samples.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: June 27, 2023
    Inventors: Christie Mitchell Ballantyne, Ron Hoogeveen, Vijay Nambi, Lloyd E. Chambless
  • Publication number: 20180203022
    Abstract: The present disclosure relates to the field of laboratory diagnostics. Specifically, methods are disclosed for determining a patient's risk of suffering from heart failure (HF) based on the detection of NT-proBNP, troponin T, and/or a natriuretic peptide. Also disclosed are methods for improving both the accuracy and speed of HF risk models by incorporating biomarker data from patient samples.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Christie Mitchell Ballantyne, Ron Hoogeveen, Vijay Nambi, Lloyd E. Chambless
  • Publication number: 20160274127
    Abstract: The present disclosure relates to the field of laboratory diagnostics. Specifically, methods are disclosed for determining a patient's risk of suffering from heart failure (HF) based on the detection of NT-proBNP, troponin T, and/or a natriuretic peptide. Also disclosed are methods for improving both the accuracy and speed of HF risk models by incorporating biomarker data from patient samples.
    Type: Application
    Filed: September 30, 2015
    Publication date: September 22, 2016
    Inventors: Christie Mitchell Ballantyne, Ron Cornelis Hoogeveen, Vijay Nambi, Lloyd E. Chambless
  • Publication number: 20140273273
    Abstract: The present disclosure relates to the field of laboratory diagnostics. Specifically, methods are disclosed for determining a patient's risk of suffering from heart failure (HF) based on the detection of NT-proBNP, troponin T, and/or a natriuretic peptide. Also disclosed are methods for improving both the accuracy and speed of HF risk models by incorporating biomarker data from patient samples.
    Type: Application
    Filed: October 31, 2013
    Publication date: September 18, 2014
    Inventors: Christie Mitchell Ballantyne, Ron Cornelis Hoogeveen, Vijay Nambi, Lloyd E. Chambless